HIGHLIGHTS
- who: Familial adenomatous polyposis and colleagues from the Departments of Gastroenterology and Hepatology, Radboud University The Netherlands have published the research work: Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial, in the Journal: Neurology
- what: The aim of the present randomized controlled trial was to examine the effect of celecoxib plus UDCA co-treatment, in comparison to celecoxib plus placebo, on duodenal adenomatosis in patients with FAP. As the participants already were under regular endoscopic surveillance and a chemopreventive option to their benefit . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.